v3.25.2
SCHEDULE OF RECONCILIATION OF THE STATEMENTS OF CASH FLOWS (Details) - USD ($)
 3 Months Ended 12 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:          
Net income (loss) $ (361,034) $ (860,549) $ (2,899,115) $ (7,231,317) $ (5,662,918)
Adjustments to reconcile net loss to net cash used in operations:          
Depreciation and amortization       43,332 130,554
Share-based compensation 113,818 119,919 386,560 1,155,480 2,104,126
Debt discount for warrants       2,041,490 1,488,928
Impairment of goodwill       1,271,306 [1]
Loss on disposal of equipment       31,000 (327,608)
Prepaid expenses       81,317 4,862
Other liabilities       207,938
Accounts payable and accrued expenses       757,317 331,748
Net cash (used in) operating activities       (1,642,136) (1,930,308)
Cash flows from financing activities:          
Payment of notes payable       (227,251) (761,671)
Proceeds from issuance of notes payable       1,806,751 2,750,646
Proceeds from common stock issuance       25,000 26,240
Net cash provided by financing activities       1,604,500 2,015,215
Net (decrease) increase in cash and cash equivalents       (37,636) 34,907
Cash and cash equivalents at the beginning of the period     110,606 110,606 75,699
Cash and cash equivalents at the end of the period       72,970 110,606
Previously Reported [Member]          
Cash flows from operating activities:          
Net income (loss) (358,845) (782,584) (2,771,331) (4,915,167)  
Adjustments to reconcile net loss to net cash used in operations:          
Depreciation and amortization       43,332  
Share-based compensation 113,818 119,919 386,560 1,155,480  
Debt discount for warrants       2,041,490  
Impairment of goodwill [1]        
Loss on disposal of equipment       31,000  
Prepaid expenses       51,000  
Other liabilities        
Accounts payable and accrued expenses       413,335  
Net cash (used in) operating activities       (1,179,530)  
Cash flows from financing activities:          
Payment of notes payable       (227,251)  
Proceeds from issuance of notes payable       1,344,145  
Proceeds from common stock issuance       25,000  
Net cash provided by financing activities       1,141,894  
Net (decrease) increase in cash and cash equivalents       (37,636)  
Cash and cash equivalents at the beginning of the period     110,606 110,606  
Cash and cash equivalents at the end of the period       72,970 110,606
Revision of Prior Period, Adjustment [Member]          
Cash flows from operating activities:          
Net income (loss) $ (2,189) (77,965) (127,784) (2,316,150)  
Adjustments to reconcile net loss to net cash used in operations:          
Depreciation and amortization        
Share-based compensation    
Debt discount for warrants        
Impairment of goodwill [1]       1,271,306  
Loss on disposal of equipment        
Prepaid expenses       30,317  
Other liabilities       207,938  
Accounts payable and accrued expenses       343,982  
Net cash (used in) operating activities       (462,606)  
Cash flows from financing activities:          
Payment of notes payable        
Proceeds from issuance of notes payable       462,606  
Proceeds from common stock issuance        
Net cash provided by financing activities       462,606  
Net (decrease) increase in cash and cash equivalents        
Cash and cash equivalents at the beginning of the period      
Cash and cash equivalents at the end of the period      
[1] Based on an annual review performed on December 31, 2023, the Company determined that its goodwill and intangible assets had been fully impaired and recorded an impairment charge amounting to $1,271,306.